Is France leading the way on nuclear?

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

Why should the 97% of non-French listeners of the podcast be interested in the fate of the French nuclear fleet? With 60GW and 56 reactors, the French nuclear fleet is critical to the very existence of a European Power market as it represents 10%-15% of the electricity consumed o ...  Show more

Is nuclear energy ‘sustainable’ and deserving of tax breaks? It’s a question dividing member states of the European Union which is considering what role nuclear should play in efforts to wean the continent off fossil fuels. Germany announced it would phase out its existing nuclea ...  Show more

What’s led the world to restart the stalled atomic engine?

2022 was a year of important milestones for nuclear power. The most significant piece of climate legislation in US history – the IRA – included tax incentives and investment for the nu ...

Stephen Sackur speaks to Rafael Grossi, director general of the world’s nuclear watchdog, the International Atomic Energy Agency. He’s been to Ukraine and has visited Putin in his continuing efforts to avert disaster at Europe’s biggest nuclear power plant. Is the Ukraine war a l ...  Show more